Caffeine metabolite nootropic with a lower anxiogenic profile than caffeine.
WHAT IS PARAXANTHINE?
Paraxanthine (1,7-dimethylxanthine) is the primary human metabolite of caffeine, generated by hepatic CYP1A2 demethylation (~84% of a caffeine dose). It is an adenosine A1/A2A receptor antagonist plus phosphodiesterase inhibitor – sharing caffeine`s vigilance-promoting profile but with **lower adenosine A2B affinity**, reducing the anxiogenic side-effect. A 2022 RCT (PMID 35008471) showed 200 mg paraxanthine improved reaction time, sustained attention, and reduced muscular fatigue in healthy adults. The 2021 PK study PMID 33806281 reports higher oral bioavailability and a peak plasma concentration 2-3 hours faster than caffeine. **The ENFINITY brand received FDA-NDI status in 2022** for use as a dietary ingredient.
Mechanism
Adenosine A1/A2A antagonist + PDE inhibitor
Half-life
3-4 h (faster peak than caffeine)
Legal status
Dietary supplement (FDA-NDI 2022)
Safety
Side effects · 7
Contraindications · 6
Related Nootropics
Telegram
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.